PGS _ Sam here
>>Is DNDN the first stock you've followed that is being manipulated as such?<<
Tricky phrasing with the “as such”. Certainly GNTA, IDEV and DSCO qualify as others I have followed, however, I do not ascribe their manipulation to BigPharma. Could be, but I was not interested in that detail. For DNDN, I find it most probable that BigPharma is involved.
>>I've heard one of the world leaders in TRP research (if not THE leader) talk and express the opinion that he doesn't yet have a handle on the realistic prospects of targeting these channels with drugs. …. Perhaps DNA returning... err... DNDN reacquiring full rights to the program is a validation of this scientist's comments?<<
OK, perhaps, or perhaps Basel told Lev that he needs to stop schmoozing with the future competition. Things are about to heat up.
Has our back and forth been your first mention of the world leader’s view of Trp-p8? How long ago did you get this earful? sam
Market Data 
Markets 
AI
